In 1983 Atari's research lab in Sunnyvale designed AMY, the "Additive Music sYnthesizer": a sound chip that built every sound from pure sine waves. 64 sine oscillators, shared among up to 8 voices,…

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

More than 120,000 people in the U.S. are living with acute lymphoblastic leukemia (ALL), and 6,000 new cases are diagnosed each year.

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

Library Secrets - Biomedical pictures for November 2026.

Smart watches already measure our pulse, steps and sleep. The next big step would be to be able to monitor blood sugar as well, without needles. Cambridge University researchers seem to be moving in this direction, having created a tiny optical sensor to monitor various health indicators. The device is a few centimeters in size. The study, published in Nature Photonics…

More than 120,000 people in the U.S. are living with acute lymphoblastic leukemia (ALL), and 6,000 new cases are diagnosed each year. Of those, more than 3,500 will be in children. Responsible for 75% of all pediatric leukemia diagnoses, ALL is a rapid-onset blood cancer, preventing the body from producing mature, infection-fighting white blood cells, sometimes within a matter of months. ALL requires immediate treatment, often a combination of chemotherapy, targeted therapy, immunotherapy and bone marrow transplants-but clinicians today have no way of knowing how specific drug combinations and dosages will impact the patient, or whether the treatment will be successful. Currently, treatment strategies incorporate some degree of personalization based on leukemia subtype and risk classification. Despite this, most patients ultimately receive similar treatment regimens. While advances in genomic sequencing have raised the possibility of truly personalized therapy, new complementary functional assays are still necessary to test live cancer cells directly against treatments to see which interventions actually work. Two patients can have the same genetic mutation but have very different responses to targeted therapy. To address this, a team of scientists and clinicians at Emory University, Children's Healthcare of Atlanta and Georgia Tech developed a groundbreaking new technology to...

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

Artificial intelligence lab Anthropic is actively hedging its hardware bets by distributing its computational workload across multiple chip families, a

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...

Cambridge researchers have created a groundbreaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology. It identified foods, plasti...